Shareholder Information
Share management and AGM information
Jefferies Healthcare Conference
June 8 2022 Download (553KB)Q1 2022 Financial Results
April 28 2022 Download (627KB)Annual Report and Accounts 2021
March 30 2022 Download (4.71MB)Q4 and FY 2021 Results
February 16 2022 Download (562KB)Jefferies 2021 London Healthcare Conference
November 16 2021 Download (791KB)Indivior Names Nina DeLorenzo Chief Global Impact Officer
June 16 2022Indivior Announces Seven Abstracts Accepted for Presentation at the 84th Annual Scientific Meeting of the College on Problems of Drug Dependence (CPDD)
June 8 2022Indivior Announces First Patient Included in Aelis Farma’s Phase 2b Study Assessing the Efficacy, Safety and Tolerability of AEF0117 in Treatment-Seeking Subjects With Moderate to Severe Cannabis Use Disorder
June 1 2022Indivior Announces Publication of Data Showing Psychosocial Benefits from a 4-year Post-Clinical Trial Outcomes Study
May 26 2022Indivior to Participate in Jefferies 2022 Healthcare Conference
May 26 2022